Qvigstad Elisabeth
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Eur J Endocrinol. 2018 Mar;178(3):C1-C5. doi: 10.1530/EJE-18-0012. Epub 2018 Jan 16.
Metformin as the first drug of choice for glucose lowering in gestational diabetes (GDM) is still controversial, despite recent publications reporting similar outcomes in comparison to insulin, both for offspring and mothers. The use of metformin during pregnancy is increasing and several recent guidelines recommend metformin use in GDM pregnancies. Background, current metformin use and unresolved concerns are discussed in the context of the article from Gante and coworkers.
尽管近期有出版物报道,与胰岛素相比,二甲双胍用于降低妊娠期糖尿病(GDM)患者血糖时,对后代和母亲的结局相似,但二甲双胍作为GDM降糖的首选药物仍存在争议。孕期使用二甲双胍的情况正在增加,最近的一些指南推荐在GDM妊娠中使用二甲双胍。本文将结合甘特及其同事的文章,讨论其背景、二甲双胍的当前使用情况以及尚未解决的问题。